Rachel K. Voss

777 total citations
17 papers, 492 citations indexed

About

Rachel K. Voss is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Rachel K. Voss has authored 17 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Rachel K. Voss's work include Sarcoma Diagnosis and Treatment (5 papers), Vascular Tumors and Angiosarcomas (2 papers) and Musculoskeletal pain and rehabilitation (2 papers). Rachel K. Voss is often cited by papers focused on Sarcoma Diagnosis and Treatment (5 papers), Vascular Tumors and Angiosarcomas (2 papers) and Musculoskeletal pain and rehabilitation (2 papers). Rachel K. Voss collaborates with scholars based in United States, Australia and Italy. Rachel K. Voss's co-authors include Janice N. Cormier, Yi-Ju Chiang, Kate D. Cromwell, Jeffrey E. Lee, Chee-Chee H. Stucky, Karin Woodman, Barry W. Feig, Keila E. Torres, Christina L. Roland and Kelly K. Hunt and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Journal of the American College of Surgeons.

In The Last Decade

Rachel K. Voss

17 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel K. Voss United States 11 195 161 143 140 107 17 492
R E Partridge United Kingdom 14 92 0.5× 28 0.2× 83 0.6× 41 0.3× 41 0.4× 16 429
Arash J. Sayari United States 13 273 1.4× 52 0.3× 101 0.7× 38 0.3× 19 0.2× 79 582
Carlo Tringale United States 4 185 0.9× 182 1.1× 17 0.1× 16 0.1× 25 0.2× 5 498
Jong Jin Yoo South Korea 9 136 0.7× 41 0.3× 75 0.5× 50 0.4× 28 0.3× 20 391
Abdurhman S Al-Arfaj Saudi Arabia 12 107 0.5× 12 0.1× 81 0.6× 38 0.3× 9 0.1× 40 524
H.H.M. de Boer Netherlands 15 429 2.2× 267 1.7× 30 0.2× 148 1.1× 66 0.6× 34 740
Thomas A. Webb United States 10 100 0.5× 67 0.4× 23 0.2× 103 0.7× 22 0.2× 18 487
Yuchen Wang United States 11 137 0.7× 104 0.6× 43 0.3× 41 0.3× 23 0.2× 48 310
Luis Díez-Valladares Spain 10 324 1.7× 79 0.5× 17 0.1× 102 0.7× 57 0.5× 19 541
Ahmed S. Zakaria Canada 13 306 1.6× 51 0.3× 23 0.2× 158 1.1× 51 0.5× 82 546

Countries citing papers authored by Rachel K. Voss

Since Specialization
Citations

This map shows the geographic impact of Rachel K. Voss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel K. Voss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel K. Voss more than expected).

Fields of papers citing papers by Rachel K. Voss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel K. Voss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel K. Voss. The network helps show where Rachel K. Voss may publish in the future.

Co-authorship network of co-authors of Rachel K. Voss

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel K. Voss. A scholar is included among the top collaborators of Rachel K. Voss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel K. Voss. Rachel K. Voss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bui, Marilyn M., et al.. (2024). Non‐Islet Cell Tumor Hypoglycemia Secondary to a 20 cm Intra‐Abdominal Leiomyoma in a Male Patient: A Case Report and Literature Review. SHILAP Revista de lepidopterología. 2024(1). 6651107–6651107. 1 indexed citations
3.
Voss, Rachel K., Dario Callegaro, Yi‐Ju Chiang, et al.. (2022). Sarculator is a Good Model to Predict Survival in Resected Extremity and Trunk Sarcomas in US Patients. Annals of Surgical Oncology. 29(7). 4376–4385. 27 indexed citations
4.
Voss, Rachel K., Nader N. Massarweh, Yi‐Ju Chiang, et al.. (2021). National Utilization of Imatinib in the Management of Resected Gastrointestinal Stromal Tumors. Annals of Surgical Oncology. 28(13). 9159–9168. 2 indexed citations
5.
Voss, Rachel K., Jane C. Lin, Mohammed H. Al-Temimi, et al.. (2020). Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision. Diseases of the Colon & Rectum. 63(4). 427–440. 24 indexed citations
6.
Marcus, Rebecca, Heather A. Lillemoe, David C. Rice, et al.. (2019). Determining the Safety and Efficacy of Enhanced Recovery Protocols in Major Oncologic Surgery: An Institutional NSQIP Analysis. Annals of Surgical Oncology. 26(3). 782–790. 10 indexed citations
7.
Stucky, Chee-Chee H., Kate D. Cromwell, Rachel K. Voss, et al.. (2018). Surgeon symptoms, strain, and selections: Systematic review and meta-analysis of surgical ergonomics. Annals of Medicine and Surgery. 27. 1–8. 161 indexed citations
8.
9.
Keung, Emily Z., Yi-Ju Chiang, Rachel K. Voss, et al.. (2017). Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma. European Journal of Surgical Oncology. 44(1). 170–177. 67 indexed citations
10.
Voss, Rachel K., Yi-Ju Chiang, Keila E. Torres, et al.. (2017). Adherence to National Comprehensive Cancer Network Guidelines is Associated with Improved Survival for Patients with Stage 2A and Stages 2B and 3 Extremity and Superficial Trunk Soft Tissue Sarcoma. Annals of Surgical Oncology. 24(11). 3271–3278. 24 indexed citations
11.
Voss, Rachel K., Lei Feng, Jeffrey E. Lee, et al.. (2017). Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness. The Journal of Clinical Endocrinology & Metabolism. 102(8). 2807–2813. 37 indexed citations
12.
Voss, Rachel K., Yi-Ju Chiang, Kate D. Cromwell, et al.. (2016). Do No Harm, Except to Ourselves? A Survey of Symptoms and Injuries in Oncologic Surgeons and Pilot Study of an Intraoperative Ergonomic Intervention. Journal of the American College of Surgeons. 224(1). 16–25e1. 59 indexed citations
13.
Cormier, Janice N., et al.. (2015). Improving outcomes in patients with melanoma: strategies to ensure an early diagnosis. Patient Related Outcome Measures. 6. 229–229. 34 indexed citations
14.
Voss, Rachel K., Kate D. Cromwell, Yi‐Ju Chiang, et al.. (2015). The long‐term risk of upper‐extremity lymphedema is two‐fold higher in breast cancer patients than in melanoma patients. Journal of Surgical Oncology. 112(8). 834–840. 25 indexed citations
15.
Voss, Rachel K., et al.. (2010). Personalising margins for bladder radiotherapy. Journal of Radiotherapy in Practice. 10(2). 137–140. 1 indexed citations
16.
Hirschberg, Raimund, et al.. (1985). Organ distribution of aluminium in uremic rats: influence of parathyroid hormone and 1,25-dihydroxyvitamin D3.. PubMed. 11(2). 106–10. 13 indexed citations
17.
Voss, Rachel K., et al.. (1959). [Suppression of the hypophyseal-thyroid system as a new method of treatment of thyrotoxic diseases].. PubMed. 38. 1–29. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026